Aim: To evaluate the rates of endocrine abnormalities in survivors of childhood brain tumors and identify risk factors.
Methods: The medical charts of patients were reviewed for background, disease-related and treatment-related data. Endocrine dysfunction was determined by clinical and laboratory evaluation.